Greenlight before approval
17:29–18:54 · 85s
Liz explains a major FDA shift: companies with pending nicotine applications can market products while awaiting decisions, a move tied to Trump’s frustration.
17:29–18:54 · 85s
Liz explains a major FDA shift: companies with pending nicotine applications can market products while awaiting decisions, a move tied to Trump’s frustration.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.